Načítá se...
Chronic hepatitis C – what do the new drugs offer and who should get them first?
Until recently in the UK the treatment of HCV depended on combination regimes of interferon (IFN) and the antiviral drug ribavirin. These regimes required regular injections and were of variable duration (generally for a minimum of 12 weeks), and the use of IFN often caused unacceptable side effects...
Uloženo v:
| Vydáno v: | Clin Med (Lond) |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Royal College of Physicians
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4953742/ https://ncbi.nlm.nih.gov/pubmed/25824075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7861/clinmedicine.15-2-197 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|